Skip to content

EU · EudraLex Vol.4

EU GMP Part I, Chapter 4

Documentation

Status of the document: revision 1

Table of contents

  1. PrinciplePrinciple
  2. 4.1All types of document should be defined and adhered to. The requirements apply equally to all forms of document media types. Complex system…
  3. 4.2Documents should be designed, prepared, reviewed, and distributed with care. They should comply with the relevant parts of Product Specific…
  4. 4.3Documents containing instructions should be approved, signed and dated by appropriate and authorised persons. Documents should have unambig…
  5. 4.4Documents containing instructions should be laid out in an orderly fashion and be easy to check. The style and language of documents should…
  6. 4.5Documents within the Quality Management System should be regularly reviewed and kept up-to-date.
  7. 4.6Documents should not be hand-written; although, where documents require the entry of data, sufficient space should be provided for such ent…
  8. 4.7Handwritten entries should be made in clear, legible, indelible way.
  9. 4.8Records should be made or completed at the time each action is taken and in such a way that all significant activities concerning the manuf…
  10. 4.9Any alteration made to the entry on a document should be signed and dated; the alteration should permit the reading of the original informa…
  11. 4.10It should be clearly defined which record is related to each manufacturing activity and where this record is located. Secure controls must…
  12. 4.11Specific requirements apply to batch documentation which must be kept for one year after expiry of the batch to which it relates or at leas…
  13. 4.12For other types of documentation, the retention period will depend on the business activity which the documentation supports. Critical docu…
  14. 4.13There should be appropriately authorised and dated specifications for starting and packaging materials, and finished products.
  15. 4.14Specifications for starting and primary or printed packaging materials should include or provide reference to, if applicable: a) A descript…
  16. 4.15Specifications for intermediate and bulk products should be available for critical steps or if these are purchased or dispatched. The speci…
  17. 4.16Specifications for finished products should include or provide reference to: a) The designated name of the product and the code reference w…
  18. 4.17The Manufacturing Formula should include: a) The name of the product, with a product reference code relating to its specification; b) A des…
  19. 4.18The Processing Instructions should include: a) A statement of the processing location and the principal equipment to be used; b) The method…
  20. 4.19Approved Packaging Instructions for each product, pack size and type should exist. These should include, or have a reference to, the follow…
  21. 4.20A Batch Processing Record should be kept for each batch processed. It should be based on the relevant parts of the currently approved Manuf…
  22. 4.21A Batch Packaging Record should be kept for each batch or part batch processed. It should be based on the relevant parts of the Packaging I…
  23. 4.22There should be written procedures and records for the receipt of each delivery of each starting material, (including bulk, intermediate or…
  24. 4.23The records of the receipts should include: a) The name of the material on the delivery note and the containers; b) The "in-house" name and…
  25. 4.24There should be written procedures for the internal labeling, quarantine and storage of starting materials, packaging materials and other m…
  26. 4.25There should be written procedures for sampling, which include the methods and equipment to be used, the amounts to be taken and any precau…
  27. 4.26There should be written procedures for testing materials and products at different stages of manufacture, describing the methods and equipm…
  28. 4.27Written release and rejection procedures should be available for materials and products, and in particular for the certification for sale o…
  29. 4.28Records should be maintained for the distribution of each batch of a product in order to facilitate recall of any batch, if necessary.
  30. 4.29There should be written policies, procedures, protocols, reports and the associated records of actions taken or conclusions reached, where…
  31. 4.30Clear operating procedures should be available for major items of manufacturing and test equipment.
  32. 4.31Logbooks should be kept for major or critical analytical testing, production equipment, and areas where product has been processed. They sh…
  33. 4.32An inventory of documents within the Quality Management System should be maintained.
Cover page and contents (original)

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL

Public Health and Risk Assessment Pharmaceuticals

Brussels, SANCO/C8/AM/sl/ares(2010)1064587

EudraLex The Rules Governing Medicinal Products in the European Union

Volume 4 Good Manufacturing Practice Medicinal Products for Human and Veterinary Use

Chapter 4: Documentation

Legal basis for publishing the detailed guidelines: Article 47 of Directive 2001/83/EC on the Community code relating to medicinal products for human use and Article 51 of Directive 2001/82/EC on the Community code relating to veterinary medicinal products. This document provides guidance for the interpretation of the principles and guidelines of good manufacturing practice (GMP) for medicinal products as laid down in Directive 2003/94/EC for medicinal products for human use and Directive 91/412/EEC for veterinary use.

Status of the document: revision 1

Reasons for changes: the sections on "generation and control of documentation" and "retention of documents" have been revised, in the light of the increasing use of electronic documents within the GMP environment.

Deadline for coming into operation: 30 June 2011

Commission Européenne, B-1049 Bruxelles / Europese Commissie, B-1049 Brussel - Belgium Telephone: (32-2) 299 11 11

Table of Contents

Principle Required GMP Documentation Generation and Control of Documentation Good Documentation Practices Retention of Documents Specifications Manufacturing Formula and Processing Instructions Procedures and records

Source: European Commission, DG SANTE · © European Union. Reuse is authorised provided the source is acknowledged (Commission Decision 2011/833/EU on the reuse of Commission documents). · retrieved 2026-11-15

Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.